Market Overview

CORRECTION: Neurocrine Biosciences, Inc. Reports Q4 Loss of $0.16/Share, Sales $700K; Sees FY14 Net Loss of $0.82-0.90/Share

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Earnings News Guidance

 

Related Articles (NBIX)